Industry News
AI.gov.au launches to help safe and responsible AI use
Providing guidance, tools and resources to help Australian businesses use AI safely, the Australian Government has launched the National AI Centre. [ + ]
AusBiotech responds to Budget 2026–27
The life sciences industry body has responded to measures set out in the Australian Government's Budget 2026–27, welcoming some measures while expressing caution about others. [ + ]
Queensland "clears rape kit DNA backlog"
In Queensland, all inherited sexual assault examination kits have been processed and a backlog of major crime DNA samples reduced by 70%, the government has announced. [ + ]
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection protection and control measures for returning MV Hondius passengers. [ + ]
$6.2m for nine science projects involving Japan and neighbours
Investments under the Global Science and Technology Diplomacy Fund will support nine international projects, with six to involve Japan as a key partner. [ + ]
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct will produce new and existing RNA therapeutics. [ + ]
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian biotech Cartherics has announced an enhanced partnership with Catalent. [ + ]
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. [ + ]
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry across the diverse and rapidly evolving field of lipid science. [ + ]
Noxopharm appoints Dr Olivier Laczka CEO
Australian clinical-stage biotech company Noxopharm Limited has appointed Dr Olivier Laczka as its Chief Executive Officer. [ + ]
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital cognitive tests and blood tests for people at risk of Alzheimer's. [ + ]
Australia signs AI collaboration agreement with Anthropic
To build on the National AI Plan launched last year, the Australian Government has signed a new collaborative Memorandum of Understanding with Anthropic. [ + ]
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural Cumming Global Fellows program. [ + ]
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell immunotherapy for multiple myeloma. [ + ]
Nominations now open for the 2026 NMI Measurement Awards
Until 20 May, the National Measurement Institute (NMI) is accepting nominations for the 2026 NMI National Measurement Awards. [ + ]
